New prostate cancer marker helps identify men whose cancer is likely to spread
05 Oct 2006
Prostate cancer researchers at Sydney’s Garvan Institute, supported
by the Cancer Institute NSW, have found a new marker for identifying
aggressive prostate cancers.
Many men with prostate cancer have their prostate glands removed, but
only a proportion of these men will later develop life-threatening
metastatic disease – where the cancer spreads to other parts of the
body such as the bones. This new marker can identify which men are at
the highest risk of metastatic disease at the time of their initial
surgery leading to tailored treatment for individual prostate cancer
sufferers, something that is not currently possible.
Garvan Profile: Associate Professor Sue Henshall
Garvan Profile: Dr Andrew Biankin
Research Group: Prostate Cancer
